BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  TESARO’s Mary Lynne Hedley and Lonnie Moulder Named EY National Entrepreneurs of the Year

  They were also recognized as the National Award Winners in the Life Sciences category.

  November 20, 2017

   · 

  2 min read
• Ossur Hf : Transactions in Relation to Share Buyback Program - Nov. 20, 2017

  On 15 August 2017, Ossur initiated a share buy-back program, see Company announcement no. 59/2017.

  November 20, 2017

   · 

  2 min read
• 

  FDA

  Cagent Vascular Wins CE Mark for Serranator, a Next Generation Device for Vessel Dilatation in PAD Interventions

  The Serranator is one of a family of peripheral artery disease technologies which incorporates proprietary Serration Technology to an angioplasty balloon.

  November 20, 2017

   · 

  3 min read
• Genetown

  T2 Biosystems Announces New T2Bacteria RUO Panel Data Presented at AMP 2017

  These data highlight the potential clinical value that may be achieved using the T2Bacteria Panel compared to results from blood culture.

  November 20, 2017

   · 

  6 min read
• Business

  Emerald Health Therapeutics Appoints Robert C. Hill, CPA, CA as Chief Financial Officer and Promotes Cheryl Evans, CPA, CA to Vice President Finance

  Together Mr. Hill and Ms. Evans will be responsible for leading Emerald’s financial operations and organizational functions to facilitate the significant anticipated expansion of the Company’s business.

  November 20, 2017

   · 

  5 min read
• Biotech Bay

  “Hair for the Holidays” Social Media Campaign Drives Increased Patient Awareness and New Patient Inquiries for the ARTAS Robotic Hair Restoration System

  The campaign, which is running from September to December, includes targeted, direct-to-patient advertising for robotic hair restoration with the ARTAS System on Facebook and Twitter.

  November 20, 2017

   · 

  1 min read
• Genetown

  Anthera Pharmaceuticals Announces Receipt of Nasdaq Listing Determination Notice and Plans Appeal

  Anthera plans to appeal the Staff’s determination and intends to timely request a hearing.

  November 20, 2017

   · 

  2 min read
• Drug Development

  Adocia Reports Topline Results of BioChaperone Glucagon Phase I Study

  The main objective of this study was to assess the safety and tolerability of subcutaneous single fixed doses of BioChaperone Glucagon and of GlucaGen HypoKit in subjects with type 1 diabetes.

  November 20, 2017

   · 

  5 min read
• TiGenix to Present Positive 52-Week Phase III Cx601 Data at EHA-SWG Scientific Meeting

  Phase III clinical trial of Cx601 for the treatment of complex perianal fistulas in patients with Crohn’s disease will be presented at the EHA-SWG Scientific Meeting on Shaping the Future of Mesenchymal Stromal Cells Therapy taking place from November 23-25, 2017 in Amsterdam, Netherlands.

  November 20, 2017

   · 

  4 min read
• FDA

  Novartis Drug Tasigna (Nilotinib) Secures EU Approval for First and Second-Line Treatment of Ph+ CML-CP in Children

  Tasigna is the only second-generation tyrosine kinase inhibitor currently approved in the European Union for the treatment of Ph+ CML-CP in children.

  November 20, 2017

   · 

  13 min read